- Full text PDF available (2)
- This year (0)
- Last 5 years (3)
- Last 10 years (3)
Journals and Conferences
The APOBEC3 family of cytidine deaminases mutate the cancer genome in a range of cancer types. Although many studies have documented the downstream effects of APOBEC3 activity through next-generation… (More)
BACKGROUND Understanding the cancer genome is seen as a key step in improving outcomes for cancer patients. Genomic assays are emerging as a possible avenue to personalised medicine in breast cancer.… (More)
[This corrects the article DOI: 10.1371/journal.pmed.1002204.].